Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma.

Teng, Wei; Lin, Chen-Chun; Ho, Ming-Mo; Lui, Kar-Wai; Wang, Sheng-Fu; Hsu, Chao-Wei; Lin, Shi-Ming

Teng, Wei; Lin, Chen-Chun; Ho, Ming-Mo; Lui, Kar-Wai; Wang, Sheng-Fu; Hsu, Chao-Wei; Lin, Shi-Ming.

Afiliação

Teng W; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taipei, Taiwan.
Lin CC; College of Medicine, Chang Gung University Taipei, Taiwan.
Ho MM; Institute of Clinical Medicine, National Yang-Ming University Taipei, Taiwan.
Lui KW; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taipei, Taiwan.
Wang SF; College of Medicine, Chang Gung University Taipei, Taiwan.
Hsu CW; Department of Medical Oncology, Chang Gung Memorial Hospital, Linkou Medical Center Taipei, Taiwan.
Lin SM; College of Medicine, Chang Gung University Taipei, Taiwan.

Am J Cancer Res ; 11(5): 2319-2330, 2021.

Article em En | MEDLINE | ID: mdl-34094688

Palavras-chave

AFP response; Immunotherapy; overall survival; progression-free survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google